Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
Titel:
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
Auteur:
Van Cutsem, E. Rivera, F. Berry, S. Kretzschmar, A. Michael, M. DiBartolomeo, M. Mazier, M.-A. Canon, J.-L. Georgoulias, V. Peeters, M. Bridgewater, J. Cunningham, D.